BUMADIZONE CALCIUM ANHYDROUS

Details

Stereochemistry	RACEMIC
Molecular Formula	2C19H21N2O3.Ca
Molecular Weight	690.841
Optical Activity	( + / - )
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BUMADIZONE CALCIUM ANHYDROUS

Structure Search

SMILES

[Ca++].CCCCC(C([O-])=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2.CCCCC(C([O-])=O)C(=O)N(NC3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=RKINNRASCJRSHD-UHFFFAOYSA-L

InChI=1S/2C19H22N2O3.Ca/c2*1-2-3-14-17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15;/h2*4-13,17,20H,2-3,14H2,1H3,(H,23,24);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	Ca
Molecular Weight	40.078
Charge	2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C19H21N2O3
Molecular Weight	325.3816
Charge	-1
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://www.drugs.com/international/bumadizone.html | https://www.ncbi.nlm.nih.gov/pubmed/331502

Bumadizone is a non-steroidal anti-inflammatory drug exerting analgesic, antipyretic and anti-inflammatory properties. It has been studied in the treatment of rheumatoid diseases.

Approval Year

Patents

Sample Use Guides

In Vivo Use Guide

110 mg twice daily

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Fri Dec 15 17:16:19 GMT 2023` Edited by `admin` on `Fri Dec 15 17:16:19 GMT 2023`
Record UNII	142R7TU2TN
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BUMADIZONE CALCIUM ANHYDROUS

Common Name

English

(±)-MALONIC ACID, BUTYL-, MONO(1,2-DIPHENYLHYDRAZIDE), CALCIUM SALT (2:1)

Common Name

English

PROPANEDIOIC ACID, 2-BUTYL-, 1-(1,2-DIPHENYLHYDRAZIDE), CALCIUM SALT (2:1)

Common Name

English

MALONIC ACID, BUTYL-, MONO(1,2-DIPHENYLHYDRAZIDE), CALCIUM SALT (2:1)

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID30956006